The coexistence of coronavirus disease 2019 (COVID-19) and pulmonary embolism (PE),
two life-threatening illnesses, in the same patient presents a unique challenge. Guidelines …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …

Pulmonary embolism (PE) is a significant cause of cardiovascular mortality, with varying
presentations and management challenges. Traditional treatment approaches often differ …

Pulmonary embolism (PE) continues to represent a significant health care burden and its
incidence is steadily increasing worldwide. Constantly evolving therapeutic options and the …

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The
management of PE is currently evolving given the development of new technologies and …

Pulmonary embolism (PE) treatment depends on disease severity and risk of complications.
Physician and institutional expertise may influence the use of reperfusion therapy (RT) such …

Severe traumatic brain injury (sTBI) is a silent epidemic, causing approximately 300,000
intensive care unit (ICU) admissions annually, with a 30% mortality rate. Despite worldwide …

Background Pulmonary embolism (PE) is a potentially life-threatening condition. Admission
and treatment in the intensive care unit (ICU) is an important element in critically ill PE …

Background Although pulmonary embolism (PE) and sarcopenia are common diseases,
only a few studies have assessed the impact of sarcopenia in PE on usage of reperfusion …

Acute pulmonary embolism (PE) remains a critical medical condition requiring prompt and
accurate management. The introduction and growing significance of pulmonary embolism …